Mike Moyer
Managing Director of LifeSite Advisors and Investor Relations Representative, Protallix Biotherapeutics
Replay available
Protalix BioTherapeutics, Inc. (DE) (PLX) Q4 2025 Earnings Call
Protalix BioTherapeutics, Inc. (DE) (AMEX: PLX) Q4 2025 earnings conference call, held 2026-03-18. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dror Bashan
President and Chief Executive Officer, Protallix Biotherapeutics
Ram Suvarju
Analyst, H.C. Wainwright
Gilad Mamlok
Senior Vice President and Chief Financial Officer, Protallix Biotherapeutics
John Vandermoysen
Analyst, SACS
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Protalix Biotherapeutics, Inc. (de).
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.119 Good morning, ladies and gentlemen, and welcome to Protallix Biotherapeutics 00:00:05.119 -- 00:00:10.207 Full Year 2025 Financial Results and Business Update Conference Call. 00:00:10.207 -- 00:00:12.871 As a reminder, this call is being recorded. 00:00:12.871 -- 00:00:18.419 I will now turn the conference over to Mike Moyer, Managing Director of LifeSite Advisors 00:00:18.419 -- 00:00:21.744 and Investor Relations Representative for Protallix. 00:00:21.744 -- 00:00:24.445 Thank you. You may begin. 00:00:24.803 -- 00:00:30.229 Thank you, Operator, and welcome to the Portalix Biotherapeutics Full Year 2025 Financial 00:00:30.229 -- 00:00:32.952 Results and Business Update Conference Call. 00:00:32.952 -- 00:00:36.834 With me today are Dror Bashan, President 00:00:36.937 -- 00:00:42.083 and CEO, and also with Portalix, Gilad Mamlok, Senior Vice President and Chief Financial 00:00:42.083 -- 00:00:45.967 Officer. A press release announcing the financial results and business updates were issued 00:00:45.967 -- 00:00:49.171 this morning and are available now on the Portalix website. 00:00:49.171 -- 00:00:52.675 Please take a moment to read the disclaimer about forward-looking statements in the press 00:00:52.675 -- 00:00:56.873 release. The earnings released in the teleconference include forward-looking statements. 00:00:56.873 -- 00:01:00.197 These forward-looking statements are subject to known and unknown risks and uncertainties 00:01:00.197 -- 00:01:04.183 that may cause the actual results to differ materially from the statements made. 00:01:04.183 -- 00:01:07.968 Factors that could cause actual results to differ are described in the disclaimer and 00:01:07.968 -- 00:01:11.173 in Fatalex's filings with the Securities and Exchange Co...